Navigation Links
Ranbaxy Labs' Entry Into Anti-Acne Market

Ranbaxy Laboratories' entry into the global anti-acne market is likely to be delayed as the mandatory inspection by the US Food and Drug Administration (US FDA) for the company's ANDA (Abbreviated New Drug Application) for the generic isotretinoin has been postponed. The US FDAs investigator had not yet arrived.

The US FDA has already approved its manufacturing facility for the product. A special investigator for checking the manufacturing process has, however, not arrived as per schedule.// Ranbaxy had applied for Para III filing to get the nod for marketing the generic isotretinoin.

Pharma major Roche Laboratories holds the patent for the active ingredient and markets it under the brand, Accutane. Accutane is used in the treatment of severe recalcitrant nodular acne. One other large US generic company, Mylan, is also expected to be in the race to manufacture and market the drug. The patent for isotretinoin will expire in February 2002. The worldwide sales of Accutane are about $757 million and are growing at about 8% - 10% .

The US FDA has been quite stringent in its inspections for the anti-acne drug to check for possible side effects. The drug is suspected to have side effects, particularly depression. Hence, the US FDA is expected to be quite rigid in granting approvals for this generic drug.
'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy trying to make inroads in herbal drugs market
4. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Ranbaxy opens Drug discovery centre in Gurgaon
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. SRL Ranbaxy offers quicker bird flu diagnostic test
9. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
10. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
11. Ranbaxy Expands By Acquiring A Generic Company In Belgium
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ranbaxy Labs Entry Into Anti Acne Market

(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... NEW YORK, NY (April 16, 2014) The cause ... but a new study proposes that neurons may be ... own immune system, similar to the way autoimmune diseases ... attack the body,s cells. The study was published April ... is a new, and likely controversial, idea in Parkinson,s ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
(Date:4/17/2014)... NEW YORK April 17, 2014 EcoHealth Alliance, ... public health issues, published a comprehensive review today examining ... and Marburg virus. The review calls for improved global ... such as the recent outbreak of Ebola in West ... in the countries of Guinea and Liberia. According ...
(Date:4/17/2014)... online has the potential to ward off depression among ... research published online in The Journals of ... . In the article " Internet Use and Depression ... Longitudinal Analysis ," the authors report that Internet use ... percent among their study sample. , Late-life depression ...
Breaking Medicine News(10 mins):Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2
... According to a survey done by the U.S. government it was ... among the America's elderly population//. It is said that adults aged ... estimated that the number of people addicted to drug would double ... generation is addicted to drugs due to problems such as pain, ...
... Drug addiction is becoming a significant public health probelm ... that the number of individuals with drug addiction// problems ... of 2020. ,Nearly 2.5 million Americans have ... 1999. The increasing inclination of elders to take drugs ...
... collaborate to prove through clinical trials the efficacy of ... known to cure but for which there is no ... collaboration has been approved by the board members and ... to the government for seeking funding," said Ranjit Roy ...
... has confirmed five more bird flu related deaths in Indonesia, ... team has further been sent to the northern Sumatra region, ... same family) had lived. The fifth victim was a 38-year-old ... and meat. ,,It is further suspected that eight ...
... helps to protect the lungs of premature infants from ... McMaster University researchers have reported// an early finding in ... caffeine therapy for the treatment of apnoea of prematurity. ... preterm infants, because the lungs are underdeveloped and the ...
... will not be allowed to make tall claims on their ... EU lawmakers have clamped down on misleading claims or health ... to set a common standard for vitamins, minerals and food ... manufacturers who are not able to justify their claims will ...
Cached Medicine News:Health News:Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs 2Health News:Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs 3Health News:Caffeine Therapy May Help Protect Lungs Of Premature Babies 2
(Date:1/15/2014)... Jan. 15, 2014  Novation, the leading health care supply ... IT value-added reseller (VAR) national contracts that expand its ... services at lower costs. These include manufacturer product and ... initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that ... to the announced tender offer for all of the outstanding shares ... of the waiver, the transaction is no longer conditional on OFT ... 24, 2014 following the currently scheduled expiration time, subject to the ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
... ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), ... to develop treatments in areas of oncology, cancer supportive ... service global public relations firm, to support its media ... media communications outreach program primarily aimed at introducing MuGard ...
... China, Aug. 5, 2011 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain Drugstore ... "Company"), the largest drugstore chain in China based on the ... will report its second quarter fiscal year 2011 financial results ... The Company will host a conference call, to be ...
Cached Medicine Technology:Access Pharmaceuticals Retains Edelman as Public Relations Firm 2Access Pharmaceuticals Retains Edelman as Public Relations Firm 3China Nepstar Chain Drugstore to Report Second Quarter 2011 Financial Results on August 23 2
The Aortic Root Cannulae With Vent Line are flanged, with radiopaque tips; two side holes in tip....
The KAVD Venous Cannula is the first of its kind. It is a combination of cannulae/venous line designed to "bridge the gap between the patient and the Medtronic Resting Heart System circuit....
... Medtronic Select CAP® cannulae provides a ... pressure readings. An innovative combination of ... monitoring line, the Select CAP® can ... central arterial pressure readings on which ...
Intermittent catheter...
Medicine Products: